|
SU1429031A1
(ru)
|
1986-06-20 |
1988-10-07 |
Калининский Государственный Медицинский Институт |
Способ дифференциальной диагностики гломерулонефрита и пиелонефрита
|
|
US5118614A
(en)
|
1988-01-18 |
1992-06-02 |
Tessek Sdruzeni Praha |
Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5939272A
(en)
|
1989-01-10 |
1999-08-17 |
Biosite Diagnostics Incorporated |
Non-competitive threshold ligand-receptor assays
|
|
US5028535A
(en)
|
1989-01-10 |
1991-07-02 |
Biosite Diagnostics, Inc. |
Threshold ligand-receptor assay
|
|
US5922615A
(en)
|
1990-03-12 |
1999-07-13 |
Biosite Diagnostics Incorporated |
Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
|
|
CA2072758A1
(en)
|
1990-09-14 |
1992-03-15 |
Kenneth Francis Buechler |
Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
|
|
US5955377A
(en)
|
1991-02-11 |
1999-09-21 |
Biostar, Inc. |
Methods and kits for the amplification of thin film based assays
|
|
AU1772992A
(en)
|
1991-04-10 |
1992-11-17 |
Biosite Diagnostics Incorporated |
Crosstalk inhibitors and their uses
|
|
EP0579767B1
(en)
|
1991-04-11 |
2000-08-23 |
Biosite Diagnostics Inc. |
Novel conjugates and assays for simultaneous detection of multiple ligands
|
|
US5324634A
(en)
|
1992-03-31 |
1994-06-28 |
The Research Foundation Of State University Of New York |
Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
|
|
US6019944A
(en)
|
1992-05-21 |
2000-02-01 |
Biosite Diagnostics, Inc. |
Diagnostic devices and apparatus for the controlled movement of reagents without membranes
|
|
US6143576A
(en)
|
1992-05-21 |
2000-11-07 |
Biosite Diagnostics, Inc. |
Non-porous diagnostic devices for the controlled movement of reagents
|
|
US5494829A
(en)
|
1992-07-31 |
1996-02-27 |
Biostar, Inc. |
Devices and methods for detection of an analyte based upon light interference
|
|
US5824799A
(en)
|
1993-09-24 |
1998-10-20 |
Biosite Diagnostics Incorporated |
Hybrid phthalocyanine derivatives and their uses
|
|
US6140045A
(en)
|
1995-03-10 |
2000-10-31 |
Meso Scale Technologies |
Multi-array, multi-specific electrochemiluminescence testing
|
|
US6498142B1
(en)
|
1996-05-06 |
2002-12-24 |
Curis, Inc. |
Morphogen treatment for chronic renal failure
|
|
JP4602482B2
(ja)
|
1996-05-24 |
2010-12-22 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
組織再生のモジュレーター
|
|
US5753455A
(en)
|
1996-09-03 |
1998-05-19 |
Bayer Corporation |
Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid
|
|
US6113855A
(en)
|
1996-11-15 |
2000-09-05 |
Biosite Diagnostics, Inc. |
Devices comprising multiple capillarity inducing surfaces
|
|
US5947124A
(en)
|
1997-03-11 |
1999-09-07 |
Biosite Diagnostics Incorporated |
Diagnostic for determining the time of a heart attack
|
|
US6057098A
(en)
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
|
WO1998055508A2
(en)
|
1997-06-03 |
1998-12-10 |
Sagami Chemical Research Center |
HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
|
|
US20060223077A1
(en)
|
1997-06-06 |
2006-10-05 |
Human Genome Sciences, Inc. |
207 human secreted proteins
|
|
US6218122B1
(en)
|
1998-06-19 |
2001-04-17 |
Rosetta Inpharmatics, Inc. |
Methods of monitoring disease states and therapies using gene expression profiles
|
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
AU2055400A
(en)
|
1998-12-18 |
2000-07-03 |
Human Genome Sciences, Inc. |
Prostacyclin-stimulating factor-2
|
|
IL143892A0
(en)
|
1998-12-21 |
2002-04-21 |
Univ Monash |
Kidney disease detection and treatment
|
|
US20030040617A9
(en)
|
1999-03-12 |
2003-02-27 |
Rosen Craig A. |
Nucleic acids, proteins and antibodies
|
|
US20040023293A1
(en)
*
|
1999-09-27 |
2004-02-05 |
Kreimer David I. |
Biochips for characterizing biological processes
|
|
DE60129674T2
(de)
|
2000-03-10 |
2008-06-05 |
Université De Genève |
Verfahren zur diagnose von transmissiblen spongiformen encephalopathien
|
|
RU2180965C1
(ru)
|
2000-07-03 |
2002-03-27 |
Габбасова Наталья Вадимовна |
Способ дифференциальной диагностики заболеваний почек
|
|
AU2002216273A1
(en)
|
2000-12-29 |
2002-07-16 |
Oxford Glycosciences (Uk) Limited |
Proteins, genes and their use for diagnosis and treatment of kidney response
|
|
US20060088823A1
(en)
|
2001-03-29 |
2006-04-27 |
Brian Haab |
Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification
|
|
US20040126767A1
(en)
|
2002-12-27 |
2004-07-01 |
Biosite Incorporated |
Method and system for disease detection using marker combinations
|
|
US20040253637A1
(en)
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
|
US20070015146A1
(en)
|
2001-05-22 |
2007-01-18 |
Gene Logic, Inc. |
Molecular nephrotoxicology modeling
|
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US20030003588A1
(en)
|
2001-06-28 |
2003-01-02 |
Comper Wayne D. |
Method for kidney disease detection by protein profiling
|
|
CA2454342A1
(en)
|
2001-07-24 |
2003-02-06 |
Yale University |
Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
|
|
JP2003081838A
(ja)
|
2001-09-11 |
2003-03-19 |
Rohto Pharmaceut Co Ltd |
グルコサミン製剤
|
|
US6784154B2
(en)
|
2001-11-01 |
2004-08-31 |
University Of Utah Research Foundation |
Method of use of erythropoietin to treat ischemic acute renal failure
|
|
US8404229B2
(en)
|
2001-12-07 |
2013-03-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to treat acute tubular necrosis
|
|
GB0130557D0
(en)
|
2001-12-20 |
2002-02-06 |
Serono Internat S A |
Proteins
|
|
US20070233391A1
(en)
|
2002-03-07 |
2007-10-04 |
Cambridge University Technical Service Limited (CUTS) |
Scd fingerprints
|
|
EP1532268A4
(en)
|
2002-03-21 |
2006-07-05 |
Yissum Res Dev Co |
PERIPHERAL BLOOD CELL MARKERS SUITABLE FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS AND THESE USEFUL METHODS AND KITS
|
|
US7138230B2
(en)
|
2002-12-06 |
2006-11-21 |
Renovar, Inc. |
Systems and methods for characterizing kidney diseases
|
|
US7138229B2
(en)
|
2002-12-06 |
2006-11-21 |
Renovar, Inc. |
Systems and methods for characterizing kidney diseases
|
|
WO2004005934A2
(en)
|
2002-07-04 |
2004-01-15 |
Oxford Glycosciences (Uk) Ltd |
Toxicity markers
|
|
US6941172B2
(en)
|
2002-11-18 |
2005-09-06 |
Zvi Nachum |
Method and device for restoring kidney function using electromagnetic stimulation
|
|
US20060063156A1
(en)
|
2002-12-06 |
2006-03-23 |
Willman Cheryl L |
Outcome prediction and risk classification in childhood leukemia
|
|
JP2006526140A
(ja)
|
2002-12-24 |
2006-11-16 |
バイオサイト インコーポレイテッド |
鑑別診断のためのマーカーおよびその使用方法
|
|
CN1791797A
(zh)
|
2003-03-27 |
2006-06-21 |
儿童医院医疗中心 |
用于检测肾小管细胞损伤的早发的方法和试剂盒
|
|
KR101224235B1
(ko)
|
2003-04-11 |
2013-01-25 |
메디뮨 엘엘씨 |
재조합 ｉｌ９ 항체 및 그의 용도
|
|
US7560244B2
(en)
|
2003-06-04 |
2009-07-14 |
Joslin Diabetes Center, Inc. |
Method of evaluating a subject for risk or predisposition of reduced renal function over time
|
|
US20050084880A1
(en)
|
2003-07-11 |
2005-04-21 |
Ronald Duman |
Systems and methods for diagnosing & treating psychological and behavioral conditions
|
|
ATE511550T1
(de)
|
2003-07-17 |
2011-06-15 |
Pacific Edge Biotechnology Ltd |
Marker zum nachweis von magenkrebs
|
|
US20050148029A1
(en)
|
2003-09-29 |
2005-07-07 |
Biosite, Inc. |
Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
|
|
GB0329288D0
(en)
|
2003-12-18 |
2004-01-21 |
Inverness Medical Switzerland |
Monitoring method and apparatus
|
|
CA2560200A1
(en)
|
2004-03-17 |
2005-09-22 |
Academisch Ziekenhuis Bij De Universiteit Van Amsterdam |
Cd44-targeting for reducing/preventing ischemia-reperfusion-injury
|
|
US20060204951A1
(en)
|
2004-04-26 |
2006-09-14 |
Judah Folkman |
Platelet biomarkers for the detection of disease
|
|
US20050272101A1
(en)
|
2004-06-07 |
2005-12-08 |
Prasad Devarajan |
Method for the early detection of renal injury
|
|
FR2872579B1
(fr)
|
2004-06-30 |
2006-11-24 |
Pasteur Institut |
Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha
|
|
WO2006008661A2
(en)
|
2004-07-19 |
2006-01-26 |
Neurochem (International) Limited |
Diagnostic methods of multiple organ amyloidosis
|
|
US7588892B2
(en)
|
2004-07-19 |
2009-09-15 |
Entelos, Inc. |
Reagent sets and gene signatures for renal tubule injury
|
|
EP1774338B1
(en)
|
2004-07-28 |
2009-06-03 |
F.Hoffmann-La Roche Ag |
Timp-2 as target/marker of beta cell failure
|
|
US20080090759A1
(en)
|
2004-08-30 |
2008-04-17 |
Robert Kokenyesi |
Methods and kits for predicting risk for preterm labor
|
|
US7141382B1
(en)
|
2004-10-12 |
2006-11-28 |
Parikh Chirag R |
Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
|
|
FI20050011A7
(fi)
|
2005-01-05 |
2006-07-06 |
Oy Jurilab Ltd |
Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
|
|
WO2006083986A2
(en)
|
2005-02-01 |
2006-08-10 |
Government Of The U.S.A, As Represented By The Secretary Department Of Health & Human Services |
Biomarkers for tissue status
|
|
ITVI20050059A1
(it)
|
2005-03-04 |
2006-09-05 |
Consorzio Per Gli Studi Universitari In Verona |
Nuovi biomarcatori per la diagnosi e/o la prognosi di neoplasie in animali
|
|
EP2604703B1
(en)
|
2005-03-14 |
2017-02-01 |
The Board of Trustees of the Leland Stanford Junior University |
Methods for evaluating graft survival in a solid organ transplant recipient
|
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
|
CA2603550A1
(en)
|
2005-03-31 |
2006-10-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for diagnosing and treating neuropsychiatric disorders
|
|
US20070037232A1
(en)
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
|
NZ562928A
(en)
|
2005-04-18 |
2011-01-28 |
Mitomics Inc |
Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
|
|
US20070087387A1
(en)
|
2005-04-21 |
2007-04-19 |
Prasad Devarajan |
Method for the Early Detection of Renal Disease Using Proteomics
|
|
WO2007013919A2
(en)
|
2005-07-21 |
2007-02-01 |
The Johns Hopkins University |
Methods of detecting and treating acute kidney injury
|
|
US7759077B2
(en)
|
2005-08-02 |
2010-07-20 |
Shariat Shahrokh F |
Soluble fas urinary marker for the detection of bladder transitional cell carcinoma
|
|
EP1757940A1
(en)
|
2005-08-26 |
2007-02-28 |
Cézanne S.A.S. |
In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC
|
|
CA2624569A1
(en)
|
2005-10-03 |
2007-04-12 |
Biosite Incorporated |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
|
US20080090304A1
(en)
|
2006-10-13 |
2008-04-17 |
Barasch Jonathan Matthew |
Diagnosis and monitoring of chronic renal disease using ngal
|
|
EP1777523A1
(en)
|
2005-10-19 |
2007-04-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
|
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
|
US10716749B2
(en)
|
2005-11-03 |
2020-07-21 |
Palo Alto Investors |
Methods and compositions for treating a renal disease condition in a subject
|
|
US20080133141A1
(en)
|
2005-12-22 |
2008-06-05 |
Frost Stephen J |
Weighted Scoring Methods and Use Thereof in Screening
|
|
TW200726845A
(en)
|
2006-01-02 |
2007-07-16 |
Nat Defense Medical Ct |
Biomarker molecular of renal illness and detecting method for the same
|
|
EP1977250A1
(en)
|
2006-01-20 |
2008-10-08 |
mosaiques diagnostics and therapeutics AG |
Method and markers for the diagnosis of renal diseases
|
|
US7623910B2
(en)
|
2006-03-10 |
2009-11-24 |
University Of Rochester |
ECG-based differentiation of LQT1 and LQT2 mutation
|
|
GB0605217D0
(en)
|
2006-03-15 |
2006-04-26 |
Novartis Ag |
Method and compositions for assessing acute rejection
|
|
GB0606776D0
(en)
|
2006-04-03 |
2006-05-10 |
Novartis Pharma Ag |
Predictive biomarkers for chronic allograft nephropathy
|
|
WO2007124331A2
(en)
|
2006-04-19 |
2007-11-01 |
Virginia Commonwealth University |
Cardioprotective and other uses of mammalian target of rapamycin (m-tor) inhibitors
|
|
US7662578B2
(en)
|
2006-04-21 |
2010-02-16 |
Children's Hospital Medical Center |
Method and kit for the early detection of impaired renal status
|
|
US20080090765A1
(en)
|
2006-05-25 |
2008-04-17 |
The Trustees Of Columbia University In The City Of New York |
Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
|
|
US20080038269A1
(en)
|
2006-05-25 |
2008-02-14 |
Mount Sinai Hospital |
Methods for detecting and treating kidney disease
|
|
CA2592372A1
(en)
|
2006-06-20 |
2007-12-20 |
Institut De Cardiologie De Montreal |
Angiopoietin-like 2 as a biomarker of vascular endothelial cell abnormal function and senescence
|
|
WO2008084331A2
(en)
|
2006-06-21 |
2008-07-17 |
Hopitaux Universitaires De Geneve |
Biomarkers for renal disorders
|
|
US20090298073A1
(en)
|
2006-06-30 |
2009-12-03 |
Gerhold David L |
Kidney Toxicity Biomarkers
|
|
US20090176656A1
(en)
|
2006-07-21 |
2009-07-09 |
Halloran Philip F |
Tissue rejection
|
|
GB0617429D0
(en)
|
2006-09-05 |
2006-10-18 |
Electrophoretics Ltd |
Markers of renal transplant rejection and renal damage
|
|
US20080206794A1
(en)
|
2006-09-15 |
2008-08-28 |
Renovar Incorporated |
Systems And Methods For Characterizing Contrast Induced-Nephropathy
|
|
WO2008067065A2
(en)
|
2006-10-19 |
2008-06-05 |
Shiv Srivastava |
Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
|
|
US7842472B2
(en)
|
2006-11-14 |
2010-11-30 |
Alere International |
Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
|
|
CA2665489C
(en)
|
2006-12-08 |
2017-08-29 |
The Children's Hospital Of Philadelphia |
Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
|
|
GB0701626D0
(en)
|
2007-01-22 |
2007-03-07 |
Cambridge Entpr Ltd |
Methods and biomarkers for diagnosing and monitoring psychotic disorders
|
|
DK2115477T3
(en)
|
2007-01-25 |
2015-08-10 |
Hoffmann La Roche |
USE OF IGFBP-7 IN THE EVIDENCE OF HEART FAILURE
|
|
WO2008104803A2
(en)
|
2007-02-26 |
2008-09-04 |
Oxford Genome Sciences (Uk) Limited |
Proteins
|
|
US8221995B2
(en)
|
2007-03-23 |
2012-07-17 |
Seok-Won Lee |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
|
EP2479571A3
(en)
|
2007-03-26 |
2012-09-26 |
Novartis AG |
Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
|
|
WO2008122670A2
(en)
|
2007-04-10 |
2008-10-16 |
Integragen |
Human diabetes susceptibility tnfrsf10b gene
|
|
US8080394B2
(en)
|
2007-04-27 |
2011-12-20 |
Brigham And Women's Hospital |
Method for determining predisposition to pulmonary infection
|
|
WO2008150488A1
(en)
|
2007-06-01 |
2008-12-11 |
Laboratory Corporation Of America Holdings |
Methods and systems for quantification of peptides and other analytes
|
|
WO2008154238A1
(en)
|
2007-06-06 |
2008-12-18 |
Siemens Healthcare Diagnostics Inc. |
Predictive diagnostics for kidney disease
|
|
US20090047689A1
(en)
|
2007-06-20 |
2009-02-19 |
John Kolman |
Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
|
|
WO2009006439A1
(en)
|
2007-06-29 |
2009-01-08 |
Correlogic Systems, Inc. |
Predictive markers for ovarian cancer
|
|
US20100267041A1
(en)
|
2007-09-14 |
2010-10-21 |
Predictive Biosciences, Inc. |
Serial analysis of biomarkers for disease diagnosis
|
|
US20110059537A1
(en)
|
2007-09-20 |
2011-03-10 |
Caritas St. Elizabeth's Medical Center Of Boston, Inc. |
Method for estimating risk of acute kidney injury
|
|
EP2203743A4
(en)
|
2007-09-20 |
2011-03-02 |
Univ Louisville Res Found |
PEPTIDE BIOMARKER FOR PREDICTING WEARNING OF THE KIDNEY FUNCTION AND A CHILDNESS
|
|
US8003333B2
(en)
|
2007-09-28 |
2011-08-23 |
Mayo Foundation For Medical Education And Research |
Serum biomarkers for early detection of acute cellular rejection
|
|
EP2215481B2
(en)
|
2007-11-15 |
2017-01-18 |
Bioporto Diagnostics A/S |
Diagnostic use of individual molecular forms of a biomarker
|
|
ES2372442T3
(es)
|
2007-12-10 |
2012-01-19 |
F. Hoffmann-La Roche Ag |
Seprasa como marcador para cáncer.
|
|
US8592925B2
(en)
|
2008-01-11 |
2013-11-26 |
Seiko Epson Corporation |
Functional device with functional structure of a microelectromechanical system disposed in a cavity of a substrate, and manufacturing method thereof
|
|
CN101960308B
(zh)
|
2008-02-29 |
2014-07-09 |
国立大学法人名古屋大学 |
急性肾损伤及预后推测用生物标记物以及其用途
|
|
US20090298106A1
(en)
|
2008-05-30 |
2009-12-03 |
Therapeutic Monitoring Services, L.L.C. |
Methods for Monitoring Immunosuppressant Drug Levels, Renal Function, and Hepatic Function Using Small Volume Samples
|
|
US8241861B1
(en)
|
2008-07-08 |
2012-08-14 |
Insilicos, Llc |
Methods and compositions for diagnosis or prognosis of cardiovascular disease
|
|
US7998744B2
(en)
|
2008-07-28 |
2011-08-16 |
Greenwood Genetic Center, Inc. |
Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders
|
|
WO2010022210A2
(en)
|
2008-08-21 |
2010-02-25 |
Pxbiosciences Llc |
Diagnosis and monitoring of renal failure using peptide biomarkers
|
|
JP2012501456A
(ja)
|
2008-08-28 |
2012-01-19 |
アスチュート メディカル，インコーポレイテッド |
腎損傷および腎不全の診断および予後のための方法および組成物
|
|
CA2735590A1
(en)
|
2008-08-29 |
2010-03-04 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US8501489B2
(en)
|
2008-09-26 |
2013-08-06 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Urinary biomarkers to predict long-term dialysis
|
|
WO2010045714A1
(en)
|
2008-10-20 |
2010-04-29 |
University Health Network |
Methods and compositions for the detection of ovarian cancer
|
|
EP2767833A3
(en)
|
2008-10-21 |
2014-12-17 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
WO2010048346A1
(en)
|
2008-10-21 |
2010-04-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CN104330574B
(zh)
|
2008-11-10 |
2017-04-12 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
|
US9229010B2
(en)
|
2009-02-06 |
2016-01-05 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CN102439441B
(zh)
|
2009-02-06 |
2016-03-09 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后方法和组合物
|
|
JP2012522491A
(ja)
|
2009-04-03 |
2012-09-27 |
ベジニクス ピーティーワイ リミテッド |
抗ｖｅｇｆ−ｄ抗体
|
|
US8313949B2
(en)
*
|
2009-04-16 |
2012-11-20 |
Nextcea Inc. |
Detecting phospholipidosis and diagnosing lysosomal storage disorders
|
|
AU2010240781B2
(en)
|
2009-04-23 |
2015-05-28 |
Wallac Oy |
Methods for determining maternal health risks
|
|
WO2010128158A1
(en)
|
2009-05-08 |
2010-11-11 |
Novartis Ag |
Diagnostic biomarkers for fibrotic disorders
|
|
US8974491B2
(en)
|
2009-06-23 |
2015-03-10 |
Infarct Reduction Technologies Inc. |
Methods for adaptive limb occlusion
|
|
US20120264148A1
(en)
|
2009-08-07 |
2012-10-18 |
Dashurie Nezieri |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
WO2011017685A1
(en)
|
2009-08-07 |
2011-02-10 |
Rules-Based Medicine, Inc. |
Methods and devices for detecting kidney transplant rejection
|
|
US20120315649A1
(en)
*
|
2009-08-28 |
2012-12-13 |
Astute Medical ,Inc. a corporation |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CA2774223A1
(en)
|
2009-09-21 |
2011-03-24 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
MX342967B
(es)
*
|
2009-12-20 |
2016-10-19 |
Astute Medical Inc |
Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
|
|
US20120156701A1
(en)
|
2009-12-20 |
2012-06-21 |
Joseph Anderberg |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CN102791885B
(zh)
|
2010-02-05 |
2015-09-09 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
|
EP2539712A4
(en)
|
2010-02-26 |
2013-09-18 |
Astute Medical Inc |
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
|
|
US20120329071A1
(en)
|
2010-03-05 |
2012-12-27 |
Mark Chance |
Protein biomarkers and therapeutic targets for renal disorders
|
|
US20130210043A1
(en)
|
2010-06-23 |
2013-08-15 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
NZ605698A
(en)
|
2010-06-23 |
2015-03-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US20130035290A1
(en)
|
2011-05-17 |
2013-02-07 |
Yale University |
Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury
|
|
EP2729181A4
(en)
|
2011-07-06 |
2014-12-17 |
Alere San Diego Inc |
METHOD AND COMPOSITIONS FOR CALCULATING THE PROBABILITY OF PROGRESSION OF ACUTE CHILD LENGTH
|
|
CA2846602A1
(en)
|
2011-08-26 |
2013-03-28 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP3540440B1
(en)
|
2011-12-08 |
2022-09-28 |
Astute Medical, Inc. |
Methods and uses for evaluating renal injury and renal status
|
|
CN105051542A
(zh)
*
|
2012-10-31 |
2015-11-11 |
阿斯图德医疗有限公司 |
定量的侧向流测定法
|
|
ES2774288T3
(es)
|
2012-11-09 |
2020-07-20 |
Hoffmann La Roche |
Diagnóstico basado en TnT o BNP de fibrilación auricular paroxística
|
|
JP6681195B2
(ja)
|
2013-01-17 |
2020-04-15 |
アスチュート メディカル，インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
|
TWI558403B
(zh)
|
2013-06-04 |
2016-11-21 |
中央研究院 |
富含半乳糖脂之植物萃取物及其用途
|
|
WO2014197729A1
(en)
|
2013-06-05 |
2014-12-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
KR20160039682A
(ko)
|
2013-08-07 |
2016-04-11 |
아스튜트 메디컬 인코포레이티드 |
생물학적 샘플에서 개선된 성능을 가지는 timp2에 대한 검정
|
|
AU2014346695B2
(en)
|
2013-11-06 |
2020-10-15 |
Astute Medical, Inc. |
Assays for IGFBP7 having improved performance in biological samples
|
|
CN110007084B
(zh)
|
2013-12-03 |
2022-11-18 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断和预后的方法和组合物
|
|
WO2016164854A1
(en)
|
2015-04-09 |
2016-10-13 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
KR102083104B1
(ko)
|
2015-10-08 |
2020-02-28 |
에프. 호프만-라 로슈 아게 |
수술 전 측정시 ａｋｉ 의 위험 예측을 위한 ｉｇｆｂｐ７
|
|
AU2017277305A1
(en)
|
2016-06-06 |
2018-12-20 |
Astute Medical, Inc. |
Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
|
|
EP3532101B1
(en)
|
2016-10-28 |
2021-12-08 |
Astute Medical, Inc. |
Use of antibodies to timp-2 for the improvement of renal function
|
|
CN110431422A
(zh)
|
2017-02-06 |
2019-11-08 |
机敏医药股份有限公司 |
用于肾损伤和肾衰竭的诊断和预后的方法和组合物
|
|
WO2018187453A1
(en)
|
2017-04-05 |
2018-10-11 |
Astute Medical, Inc. |
Assays for timp2 having improved performance in biological samples
|
|
WO2018208684A1
(en)
|
2017-05-07 |
2018-11-15 |
Astute Medical, Inc. |
Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy
|